Jurgi Camblong
About Jurgi Camblong
Jurgi Camblong is the Co-Founder and CEO of SOPHiA GENETICS, where he has worked since 2011. He holds a Ph.D. in life sciences from the University of Geneva and has published research in prestigious journals.
Work at SOPHiA GENETICS
Jurgi Camblong has served as the Co-Founder and CEO of SOPHiA GENETICS since its inception in 2011. Under his leadership, the company has established itself as a leader in the field of data-driven medicine. SOPHiA GENETICS is recognized for its innovative approach to genomic analysis, providing solutions that enhance the accuracy of diagnoses and treatment plans. The company has received accolades, including being named one of the 50 smartest companies by MIT Technology Review.
Education and Expertise
Jurgi Camblong holds a Ph.D. in life sciences from the University of Geneva, where he studied Molecular Biology from 2002 to 2007. He also earned a Master's degree in Biochemistry from Université de Pau et des Pays de l'Adour between 1997 and 2001. Additionally, he completed a Certificate in Marketing and Business Analysis at the University of Geneva in 2006. Camblong further advanced his education with an Executive M.B.A. in Management of Technology from HEC-EPFL Lausanne in 2012.
Background
Before co-founding SOPHiA GENETICS, Jurgi Camblong worked as a Post-doctoral Associate Researcher at the University of Geneva from 2007 to 2008. His academic journey includes a DEA in Health Biology from Université de Bordeaux, achieved in 2002. His diverse educational background has equipped him with a robust understanding of both the scientific and business aspects of biotechnology.
Achievements
Jurgi Camblong has been recognized for his contributions to the field of biotechnology. In 2017, he was named Emergent Entrepreneur of the Year by EY. He has published research in prestigious journals such as Cell, Science, and Nature, reflecting his expertise in molecular biology. Camblong has also served on the Advisory Council on Digital Transformation to the Swiss Federal Government, contributing to national discussions on technology and innovation.
Leadership Roles
In addition to his role at SOPHiA GENETICS, Jurgi Camblong is a board member of the Swiss Biotech Association. His involvement in this organization highlights his commitment to advancing the biotechnology sector in Switzerland. His leadership in various capacities demonstrates his influence in shaping the future of biotechnology and digital transformation in healthcare.